Javier Pérez Gisbert-rekin lankidetzan egindako argitalpenak (8)

2019

  1. Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386

2007

  1. 13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding

    Helicobacter, Vol. 12, Núm. 3, pp. 231-237

2006

  1. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?

    Digestive and Liver Disease, Vol. 38, Núm. 4, pp. 254-259

  2. Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: Frequency and significance of borderline δ13CO2 values

    Alimentary Pharmacology and Therapeutics, Vol. 23, Núm. 2, pp. 275-280

2003

  1. Comparación entre dos pruebas del aliento con 13C-urea para el diagnóstico de la infección por Helicobacter pylori: Espectrometría de masas frente a infrarojos

    Gastroenterologia y Hepatologia, Vol. 26, Núm. 3, pp. 141-146

2000

  1. 13C-urea breath test for the diagnosis of Helicobacter pylori infection: Are basal samples necessary?

    European Journal of Gastroenterology and Hepatology, Vol. 12, Núm. 11, pp. 1201-1205

  2. 13C-Phenylalanine and 13C-Methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease

    Digestive and Liver Disease, Vol. 32, Núm. 3, pp. 226-232

  3. 13C-urea breath test for the diagnosis of Helicobacter pylori infection before treatment: Is citric acid necessary?

    Digestive and Liver Disease, Vol. 32, Núm. 1, pp. 20-24